Class information for:
Level 1: GLYPICAN 3//GPC3//SIMPSON GOLABI BEHMEL SYNDROME

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
17632 589 38.9 89%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
6 4 GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY 1371034
78 3       HEPATOCELLULAR CARCINOMA//GASTROENTEROLOGY & HEPATOLOGY//PORTAL HYPERTENSION 80496
627 2             HEPATOCELLULAR CARCINOMA//HEPATOBLASTOMA//SORAFENIB 13826
17632 1                   GLYPICAN 3//GPC3//SIMPSON GOLABI BEHMEL SYNDROME 589

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 GLYPICAN 3 authKW 5760709 26% 71% 156
2 GPC3 authKW 1658912 7% 80% 40
3 SIMPSON GOLABI BEHMEL SYNDROME authKW 1508095 7% 73% 40
4 GLYPICAN authKW 402116 5% 24% 32
5 GPC3 GENE authKW 362891 1% 100% 7
6 SIMPSON GOLABI BEHMEL SYNDROME SGBS authKW 207366 1% 100% 4
7 GPC5 authKW 195396 1% 54% 7
8 GLYPICAN 4 authKW 186625 1% 60% 6
9 GC33 authKW 155525 1% 100% 3
10 SIMPSON GOLABI BEHMEL authKW 155525 1% 100% 3

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Oncology 1705 29% 0% 170
2 Gastroenterology & Hepatology 1464 16% 0% 92
3 Pathology 637 10% 0% 58
4 Genetics & Heredity 558 14% 0% 82
5 Cell Biology 175 11% 0% 63
6 Developmental Biology 166 4% 0% 22
7 Medicine, Research & Experimental 90 6% 0% 34
8 Immunology 76 7% 0% 43
9 Biochemistry & Molecular Biology 56 13% 0% 75
10 Medical Laboratory Technology 44 2% 0% 10

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 SECT CANC IMMUNOTHER Y 143555 1% 46% 6
2 GLYCOBIOL DEV GENET 103671 1% 25% 8
3 MED SURG IMMUNOL 93312 1% 60% 3
4 ANTIBODY THER Y SECT 77759 1% 50% 3
5 ADV GENET TECHNOL PL BIOSYST 51842 0% 100% 1
6 BIOTHER IES HEPAT 51842 0% 100% 1
7 CAMILLE DESMOULINS MATERN HOSP 51842 0% 100% 1
8 CANC UK CANC GENET GRP 51842 0% 100% 1
9 CISBI N 51842 0% 100% 1
10 CLIN GENET INGEMM GENET MED MOLCIBERER CT 51842 0% 100% 1

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 AMERICAN JOURNAL OF MEDICAL GENETICS PART A 2278 3% 0% 16
2 HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL 1936 1% 1% 6
3 AMERICAN JOURNAL OF MEDICAL GENETICS 1894 3% 0% 18
4 ONCOIMMUNOLOGY 1347 1% 1% 5
5 HEPATOLOGY 1096 3% 0% 16
6 JOURNAL OF HEPATOLOGY 810 2% 0% 11
7 LIVER INTERNATIONAL 725 1% 0% 6
8 CANCER SCIENCE 709 1% 0% 7
9 CLINICAL CANCER RESEARCH 663 2% 0% 14
10 INTERNATIONAL JOURNAL OF ONCOLOGY 641 2% 0% 11

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 GLYPICAN 3 5760709 26% 71% 156 Search GLYPICAN+3 Search GLYPICAN+3
2 GPC3 1658912 7% 80% 40 Search GPC3 Search GPC3
3 SIMPSON GOLABI BEHMEL SYNDROME 1508095 7% 73% 40 Search SIMPSON+GOLABI+BEHMEL+SYNDROME Search SIMPSON+GOLABI+BEHMEL+SYNDROME
4 GLYPICAN 402116 5% 24% 32 Search GLYPICAN Search GLYPICAN
5 GPC3 GENE 362891 1% 100% 7 Search GPC3+GENE Search GPC3+GENE
6 SIMPSON GOLABI BEHMEL SYNDROME SGBS 207366 1% 100% 4 Search SIMPSON+GOLABI+BEHMEL+SYNDROME+SGBS Search SIMPSON+GOLABI+BEHMEL+SYNDROME+SGBS
7 GPC5 195396 1% 54% 7 Search GPC5 Search GPC5
8 GLYPICAN 4 186625 1% 60% 6 Search GLYPICAN+4 Search GLYPICAN+4
9 GC33 155525 1% 100% 3 Search GC33 Search GC33
10 SIMPSON GOLABI BEHMEL 155525 1% 100% 3 Search SIMPSON+GOLABI+BEHMEL Search SIMPSON+GOLABI+BEHMEL

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref.
in cl.		 Shr. of ref. in
cl.		 Citations
1 HARUYAMA, Y , KATAOKA, H , (2016) GLYPICAN-3 IS A PROGNOSTIC FACTOR AND AN IMMUNOTHERAPEUTIC TARGET IN HEPATOCELLULAR CARCINOMA.WORLD JOURNAL OF GASTROENTEROLOGY. VOL. 22. ISSUE 1. P. 275 -283 61 79% 3
2 HO, M , KIM, H , (2011) GLYPICAN-3: A NEW TARGET FOR CANCER IMMUNOTHERAPY.EUROPEAN JOURNAL OF CANCER. VOL. 47. ISSUE 3. P. 333-338 46 96% 40
3 MOUNAJJED, T , ZHANG, LZ , WU, TT , (2013) GLYPICAN-3 EXPRESSION IN GASTROINTESTINAL AND PANCREATIC EPITHELIAL NEOPLASMS.HUMAN PATHOLOGY. VOL. 44. ISSUE 4. P. 542-550 48 87% 14
4 WANG, L , YAO, M , PAN, LH , QIAN, Q , YAO, DF , (2015) GLYPICAN-3 IS A BIOMARKER AND A THERAPEUTIC TARGET OF HEPATOCELLULAR CARCINOMA.HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL. VOL. 14. ISSUE 4. P. 361 -366 49 79% 4
5 FENG, MQ , HO, M , (2014) GLYPICAN-3 ANTIBODIES: A NEW THERAPEUTIC TARGET FOR LIVER CANCER.FEBS LETTERS. VOL. 588. ISSUE 2. P. 377-382 43 80% 22
6 WANG, SK , ZYNGER, DL , HES, O , YANG, XMJ , (2014) DISCOVERY AND DIAGNOSTIC VALUE OF A NOVEL ONCOFETAL PROTEIN: GLYPICAN 3.ADVANCES IN ANATOMIC PATHOLOGY. VOL. 21. ISSUE 6. P. 450 -460 56 65% 5
7 TENORIO, J , ARIAS, P , MARTINEZ-GLEZ, V , SANTOS, F , GARCIA-MINAUR, S , NEVADO, J , LAPUNZINA, P , (2014) SIMPSON-GOLABI-BEHMEL SYNDROME TYPES I AND II.ORPHANET JOURNAL OF RARE DISEASES. VOL. 9. ISSUE . P. - 38 86% 7
8 COTTEREAU, E , MORTEMOUSQUE, I , MOIZARD, MP , BURGLEN, L , LACOMBE, D , GILBERT-DUSSARDIER, B , SIGAUDY, S , BOUTE, O , DAVID, A , FAIVRE, L , ET AL (2013) PHENOTYPIC SPECTRUM OF SIMPSONGOLABIBEHMEL SYNDROME IN A SERIES OF 42 CASES WITH A MUTATION IN GPC3 AND REVIEW OF THE LITERATURE.AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS. VOL. 163C. ISSUE 2. P. 92-105 35 90% 17
9 CHEN, M , LI, GH , YAN, J , LU, XZ , CUI, JW , NI, ZX , CHENG, WZ , QIAN, GS , ZHANG, J , TU, H , (2013) REEVALUATION OF GLYPICAN-3 AS A SEROLOGICAL MARKER FOR HEPATOCELLULAR CARCINOMA.CLINICA CHIMICA ACTA. VOL. 423. ISSUE . P. 105-111 32 97% 17
10 TRETIAKOVA, M , ZYNGER, DL , LUAN, CY , ANDEEN, NK , FINN, LS , KOCHERGINSKY, M , TEH, BT , YANG, XMJ , (2015) GLYPICAN 3 OVEREXPRESSION IN PRIMARY AND METASTATIC WILMS TUMORS.VIRCHOWS ARCHIV. VOL. 466. ISSUE 1. P. 67 -76 35 80% 2

Classes with closest relation at Level 1


Rank Class id link
1 21520 SOTOS SYNDROME//NSD1//WEAVER SYNDROME
2 13151 HEP PAR 1//HEPATOCYTE PARAFFIN 1//FINE NEEDLE TRUCUT BIOPSY
3 6202 SYNDECAN 1//SYNDECAN//SYNDECAN 4
4 34402 AFP MRNA//ALPHA FETOPROTEIN MRNA//AFP MESSENGER RNA
5 4804 DES GAMMA CARBOXY PROTHROMBIN//ALPHA FETOPROTEIN//HEPATOCELLULAR CARCINOMA
6 24888 CANC VACCINE DEV//INNOVAT CANC THER Y//PERSONALIZED PEPTIDE VACCINE
7 13162 TWISTED GASTRULATION//BRINKER//DPP
8 4929 SORAFENIB//HEPATOCELLULAR CARCINOMA//HEPATIC ARTERIAL INFUSION CHEMOTHERAPY
9 20004 CYTOKINE INDUCED KILLER CELLS//CIK CELLS//CIK
10 9519 SILVER RUSSELL SYNDROME//BECKWITH WIEDEMANN SYNDROME//UNIPARENTAL DISOMY

Go to start page